RINREYA

Serial Number 98081534
Registration 7765100
700

Registration Progress

Application Filed
Jul 12, 2023
Under Examination
Jul 2, 2024
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered
Apr 22, 2025

Trademark Image

RINREYA

Basic Information

Serial Number
98081534
Registration Number
7765100
Filing Date
July 12, 2023
Registration Date
April 22, 2025
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 22, 2025
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
2100 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-22)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Apr 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2025 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Mar 27, 2025 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Mar 27, 2025 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 31, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 30, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 10, 2024 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
May 10, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 29, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 28, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 28, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 28, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 28, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 27, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 27, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 27, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 27, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 22, 2024 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Mar 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 9, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 18, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 15, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome

Classification

International Classes
005